Team:ULB-Brussels/mat
From 2011.igem.org
Line 1: | Line 1: | ||
<html> | <html> | ||
<head> | <head> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<style> | <style> | ||
- | + | table | |
{ | { | ||
- | + | margin: auto; | |
+ | width: 700px; | ||
+ | padding: 20px; | ||
+ | } | ||
+ | |||
+ | td | ||
+ | { | ||
+ | padding-top: 10px; | ||
+ | padding-bottom: 10px; | ||
} | } | ||
Line 123: | Line 118: | ||
{ | { | ||
width:980px; | width:980px; | ||
- | height: | + | height:860px; |
margin: auto; | margin: auto; | ||
padding-left: 5px; | padding-left: 5px; | ||
Line 132: | Line 127: | ||
float: left; | float: left; | ||
width:980px; | width:980px; | ||
+ | min-height:200px; | ||
} | } | ||
Line 153: | Line 149: | ||
{ | { | ||
float: left; | float: left; | ||
- | padding: | + | padding: 4px; |
width:980px; | width:980px; | ||
- | + | min-height: 392px; | |
border: 2px inset #27303e; | border: 2px inset #27303e; | ||
text-align: justify; | text-align: justify; | ||
Line 547: | Line 543: | ||
background-color: #690115; | background-color: #690115; | ||
} | } | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
</style> | </style> | ||
Line 578: | Line 552: | ||
<a href="https://2011.igem.org/Team:ULB-Brussels">Home</a> | <a href="https://2011.igem.org/Team:ULB-Brussels">Home</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/project">Project</a> | ||
- | <a | + | <a href="https://2011.igem.org/Team:ULB-Brussels/modeling">Modelling</a> |
- | + | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/human">Human practice</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/Results">Results</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/Results">Results</a> | ||
Line 585: | Line 558: | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/safety">Safety</a> | ||
<a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a> | <a href="https://2011.igem.org/Team:ULB-Brussels/team">Team</a> | ||
- | <a href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a> | + | <a id="couleur" href="https://2011.igem.org/Team:ULB-Brussels/sponsors">Sponsors</a> |
</div> | </div> | ||
- | |||
- | |||
- | |||
</div> | </div> | ||
Line 596: | Line 566: | ||
<div id="maintext"> | <div id="maintext"> | ||
<div id="hmaint"> | <div id="hmaint"> | ||
- | + | Sponsors </div> | |
<div id="maint"> | <div id="maint"> | ||
+ | |||
+ | |||
Line 714: | Line 686: | ||
</ul> | </ul> | ||
<p> 5’-gaccggcagcaaatg-3’<strong></strong></p> | <p> 5’-gaccggcagcaaatg-3’<strong></strong></p> | ||
- | |||
Line 727: | Line 698: | ||
<div id="bas"> | <div id="bas"> | ||
<div id="basi"> | <div id="basi"> | ||
- | iGEM ULB Brussels Team - <a href="mailto: | + | iGEM ULB Brussels Team - <a href="mailto:sgerard@ulb.ac.be">Contact us</a> |
</div> | </div> | ||
</div> | </div> | ||
</html> | </html> |
Revision as of 13:22, 21 September 2011
Primers
The following primers were produced by Sigma-Aldrich (option desalt)
Yeast cloning:
- PKD46-FOR:
5’- gagcaaaaggccagcaaaaggccaggaaccgtaaaaaggctgccacctgcatcgatttat-3’
- PKD46-REV:
5’-cgtgagttttcgttccactgagcgtcagaccccgtagaaagagttttcgttccactgagc-3’
- PFL-FOR:
5’-Gcctttttacggttcctggc-3’
- PFL-REV:
5’-tttctacgggggtctgacgc-3’
- PCP-FOR:
5’-tggctcttgtatctatcagtgaagcatcaagactaacaaatcagccaaacgtctcttcag-3’
- PCP-REV:
5’-ggggctgtatgcacaaagcatcttctgttgagttaagaacttatatgcgtctatttatgtagg-3’
In green is the 40 homologous nucleotides need for the yeast cloning.
Yeast cloning verification:
- FLP/CI-FOR:
5’-Acatggcgagttttgacgag-3’
- FLP/CI-REV:
5’-accacactagagaacatactg-3’
pINDEL sequencing:
- pID-seq1:
5’-aggatcttcacctagatcctt-3’
- pID-seq2:
5’-gatgggctagtcaatgataatta-3’
- pID-seq3:
5’-ccgttacgtaggtaggaatc-3’
- pID-seq4:
5’-agatggggatggggcagtc-3’
- pID-seq5:
5’-gatttcggatcaacgttcttaat-3’
- pID-seq6:
5’-caatcactttcgtctactcc-3’
- pID-seq7:
5’-ccagatatttcgccgcgac-3’
- pID-seq8:
5’-cggggccagcaaaaaatcca-3’
- pID-seq9:
5’-ccctgatttttcaccacccc-3’
- pID-seq10:
5’-cttccgaaaatgcaacgcga-3’
Biobrick frt’-cm-frt’
- frt’-cm-frt’-for:
5’-gaagttcctatactttttagagaataggaacttcgttgatcgggcacgtaagagg-3’
- frt’-cm-frt’-rev :
5’-gaagttcctattctctaaaaagtataggaacttcttattacgccccgccctgcc-3’
In green is the frt’ sequence which is not homologous with the chloramphenicol gene.
- topo-frt’-cm-frt’-for:
5'-tccggcaaaaaagggcaaggtgtcaccaccctgcccttttcgccagtgtgctggatttc-3'
- topo-frt’-cm-frt’-rev:
5’-tgcagcggccgctactagtactctagaagcggccgcgaatgatggatatctgcagatttc-3’
In red is the iGEM restriction sites (prefix and suffix) and in green is the mutation made to suppress the EcoRI restriction site (in the Topo® XL PCR plasmid).
Biobrick frt’-cm-frt’ sequencing (primer M13 as described in Topo® XL PCR Kit)
- FRT’-cm-FRT’-SEQ-FOR:
5’-Gaggaaacagctatga-3’
- FRT’-cm-FRT’-SEQ-REV:
5’-gaccggcagcaaatg-3’